Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Consider index investing for broad diversification and low costs after establishing risk tolerance and goals. This guide points to ideal moments.
13,296 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Remote work demand worldwide is shifting how companies hire, spend, and allocate capital. This in-depth guide breaks ...
Defense-tech pioneer Palmer Luckey calls for public-oversight over AI, arguing government power should guide how AI i...
UBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
As planet labs (pl) 2026 nears, investors weigh growth against costs in a fast-evolving space data market. This guide...
When markets slump, two crypto giants throw up different signals. This guide breaks down the case for Bitcoin as the ...
As HubSpot prepares to report its 2026 earnings, investors want clarity on growth drivers, profitability, and strateg...
Karman Space & Defense reported a solid quarter, but its stock slipped. This article breaks down the factors behind t...
ARK’s latest AI IPO move put Cerebras at the center of a hype-filled market. Before you copy a big bet, learn the rea...
Investing in metals companies can feel like chasing a treasure chest. This deep-dive explains the opportunities, the ...
Two giants in the U.S. cannabis space face off for investors: Green Thumb Industries and Curaleaf. This guide breaks ...
SpaceX's IPO hype is hard to ignore, but there are four solid concerns investors should weigh before buying in. This ...